Advanced search
Publication Cover
Expert Review of Vaccines Volume 13, 2014 - Issue 2
Submit an article Journal homepage
319
Views
5
CrossRef citations to date
0
Altmetric
Perspectives

Is administration of the HPV vaccine during pregnancy feasible in the future?

Abbey B BerensonDepartment of Obstetrics and Gynecology and the Center for Interdisciplinary Research in Women’s Health, The University of Texas Medical Branch, Galveston, TX, USACorrespondence[email protected]
,
Pooja R PatelDepartment of Obstetrics and Gynecology and the Center for Interdisciplinary Research in Women’s Health, The University of Texas Medical Branch, Galveston, TX, USA
&
Alan D BarrettDepartment of Pathology and the Sealy Center for Vaccine Development, The University of Texas Medical Branch, Galveston, TX, USA
Pages 213-219 | Published online: 28 Nov 2013

References

  • Pisani P. The cancer burden and cancer control in developing countries. Environ. Health 10( Suppl. 1), S2 (2011).
  • Markowitz LE, Hariri S, Lin C et al. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003–2010. J. Infect. Dis. 208(3), 385–393 (2013).
  • Laz TH, Rahman M, Berenson AB. An update on human papillomavirus vaccine uptake among 11-17 year old girls in the United States: National Health Interview Survey, 2010. Vaccine 30(24), 3534–3540 (2012).
  • Zimet GD, Shew ML, Kahn JA. Appropriate use of cervical cancer vaccine. Annu. Rev. Med. 59, 223–236 (2008).
  • Wright JD, Govindappagari S, Pawar N et al. Acceptance and compliance with postpartum human papillomavirus vaccination. Obstet. Gynecol. 120(4), 771–782 (2012).
  • Dobson SR, McNeil S, Dionne M et al. Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial. JAMA 309(17), 1793–1802 (2013).
  • Sarah French LM. Vaccinations in pregnancy. Obstet. Gynaecol. Reprod. Med. 23(2), 38–44 (2013).
  • Brent RL. Immunization of pregnant women: reproductive, medical and societal risks. Vaccine 21(24), 3413–3421 (2003).
  • Munoz FM. Safety of influenza vaccines in pregnant women. Am. J. Obstet. Gynecol. 207( 3 Suppl.), S33–S37 (2012).
  • American College of Obstetricians and Gynecologists Committee on Obstetric Practice. ACOG Committee Opinion No. 468: influenza vaccination during pregnancy. Obstet. Gynecol. 116(4), 1006–1007 (2010).
  • Bischoff AL, Følsgaard NV, Carson CG et al. Altered response to A (H1N1) pnd09 vaccination in pregnant women: a single blinded randomized controlled trial. PLoS ONE 8(4), e56700 (2013).
  • Zaman K, Roy E, Arifeen SE et al. Effectiveness of maternal influenza immunization in mothers and infants. N. Engl. J. Med. 359(15), 1555–1564 (2008).
  • American College of Obstetricians and Gynecologists Committee on Obstetric Practice. ACOG Committee Opinion No. 521: update on immunization and pregnancy: tetanus, diphtheria, and pertussis vaccination. Obstet. Gynecol. 119(3), 690–691 (2012).
  • Centers for Disease Control and Prevention. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb. Mortal. Wkly Rep. 62(7), 131–135 (2013).
  • Centers for Disease Control & Prevention. advisory committee on immunization practices (ACIP) recommended immunization schedules for persons aged 0 through 18 years and adults aged 19 years and older--United States, 2013. MMWR Surveill. Summ. 62 ( Suppl. 1), 1 (2013).
  • Baker CJ, Rench MA, McInnes P. Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine. Vaccine 21(24), 3468–3472 (2003).
  • Harrison LH, Elliott JA, Dwyer DM et al. Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland emerging infections program. J. Infect. Dis. 177(4), 998–1002 (1998).
  • Johri AK, Paoletti LC, Glaser P et al. Group B Streptococcus: global incidence and vaccine development. Nat. Rev. Microbiol. 4(12), 932–942 (2006).
  • Dana A, Buchanan KM, Goss MA et al. Pregnancy outcomes from the pregnancy registry of a human papillomavirus type 6/11/16/18 vaccine. Obstet. Gynecol. 114(6), 1170–1178 (2009).
  • Descamps D, Hardt K, Spiessens B et al. Safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention: a pooled analysis of 11 clinical trials. Hum. Vaccin. 5(5), 332–340 (2009).
  • Wacholder S, Chen BE, Wilcox A et al. Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials. BMJ 340, c712 (2010).
  • Garland SM, Ault KA, Gall SA et al. Pregnancy and infant outcomes in the clinical trials of a human papillomavirus type 6/11/16/18 vaccine: a combined analysis of five randomized controlled trials. Obstet. Gynecol. 114(6), 1179–1188 (2009).
  • American College of Obstetricians and Gynecologists. ACOG committee opinion no. 558: Integrating immunizations into practice. Obstet. Gynecol. 121(4), 897–903 (2013).
  • Favre M, Majewski S, De Jesus N, Malejczyk M, Orth G, Jablonska S. A possible vertical transmission of human papillomavirus genotypes associated with epidermodysplasia verruciformis. J. Invest. Dermatol. 111(2), 333–336 (1998).
  • Pakarian F, Kaye J, Cason J et al. Cancer associated human papillomaviruses: perinatal transmission and persistence. Br. J. Obstet. Gynaecol. 101(6), 514–517 (1994).
  • Puranen MH, Yliskoski MH, Saarikoski SV, Syrjänen KJ, Syrjänen SM. Exposure of an infant to cervical human papillomavirus infection of the mother is common. Am. J. Obstet. Gynecol. 176(5), 1039–1045 (1997).
  • Tenti P, Zappatore R, Migliora P, Spinillo A, Belloni C, Carnevali L. Perinatal transmission of human papillomavirus from gravidas with latent infections. Obstet. Gynecol. 93(4), 475–479 (1999).
  • Tseng CJ, Liang CC, Soong YK, Pao CC et al. Perinatal transmission of human papillomavirus in infants: relationship between infection rate and mode of delivery. Obstet. Gynecol. 91(1), 92–96 (1998).
  • Tseng CJ, Lin CY, Wang RL et al. Possible transplacental transmission of human papillomaviruses. Am. J. Obstet. Gynecol. 166(1 Pt 1), 35–40 (1992).
  • Wang X, Zhu Q, Rao H. Maternal-fetal transmission of human papillomavirus. Chin. Med. (Engl.) 111(8), 726–727 (1998).
  • Trottier H. Epidemiology of mucosal human papillomavirus (HPV) infections among adult, adolescent and child. In: Human Papillomavirus and Related Diseases – From Bench to Bedside- A Clinical Perspective. Broeck DV ( Ed.). Intech, Croatie (2012).
  • Xu S, Liu L, Lu S, Ren S. Clinical observation on vertical transmission of human papillomavirus. Chin. Med. Sci. J. 13(1), 29–31 (1998).
  • Green J, Monteiro E, Bolton VN, Sanders P, Gibson P. Detection of human papillomavirus DNA by PCR in semen from patients with and without penile warts. Genitourin. Med. 67(3), 207–210 (1991).
  • Pakendorf UW, Bornman MS, Du Plessis DJ. Prevalence of human papilloma virus in men attending the infertility clinic. Andrologia 30(1), 11–14 (1998).
  • Rintala MA, Pöllänen PP, Nikkanen VP et al. Human papillomavirus DNA is found in the vas deferens. J. Infect. Dis. 185(11), 1664–1667 (2002).
  • McDonnell PJ, McDonnell JM, Kessis T et al. Detection of human papillomavirus type 6/11 DNA in conjunctival papillomas by in situ hybridization with radioactive probes. Hum. Pathol. 18(11), 1115–1119 (1987).
  • Rock B, Naghashfar Z, Barnett N, Buscema J, Woodruff JD, Shah K. Genital tract papillomavirus infection in children. Arch. Dermatol. 122(10), 1129–1132 (1986).
  • Silverberg MJ, Thorsen P, Lindeberg H, Grant LA, Shah KV. Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis. Obstet. Gynecol. 101(4), 645–652 (2003).
  • Smith EM, Johnson SR, Cripe TP, Pignatari S, Turek L. Perinatal vertical transmission of human papillomavirus and subsequent development of respiratory tract papillomatosis. Ann. Otol. Rhinol. Laryngol. 100(6), 479–478 (1991).
  • Kashima HK, Shah F, Lyles A et al. A comparison of risk factors in juvenile-onset and adult-onset recurrent respiratory papillomatosis. Laryngoscope 102(1), 9–13 (1992).
  • Smith EM, Ritchie JM, Yankowitz J et al. Human papillomavirus prevalence and types in newborns and parents: concordance and modes of transmission. Sex Transm. Dis. 31(1), 57–62 (2004).
  • Dillner J, Andersson-Ellström A, Hagmar B, Schiller J. High risk genital papillomavirus infections are not spread vertically. Rev. Med. Virol. 9(1), 23–29 (1999).
  • Castellsagué X, Drudis T, Cañadas MP et al. Human Papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes: a prospective study in Spain. BMC Infect Dis. 9:74 (2009).
  • Syrjänen S. Current concepts on human papillomavirus infections in children. APMIS 118(6–7), 494–509 (2010).
  • Winer RL, Koutsky LA. Delivering reassurance to parents: perinatal human papillomavirus transmission is rare. Sex Transm. Dis. 31(1), 63–64 (2004).
  • Shah KV, Stern WF, Shah FK, Bishai D, Kashima HK. Risk factors for juvenile onset recurrent respiratory papillomatosis. Pediatr. Infect. Dis. J. 17(5), 372–376 (1998).
  • Shah K, Kashima H, Polk BF, Shah F, Abbey H, Abramson A. Rarity of cesarean delivery in cases of juvenile-onset respiratory papillomatosis. Obstet. Gynecol. 68(6), 795–799 (1986).
  • Medeiros LR, Ethur AB, Hilgert JB et al. Vertical transmission of the human papillomavirus: a systematic quantitative review. Cad. Saude Publica. 21(4), 1006–1015 (2005).
  • Park H, Lee SW, Lee IH et al. Rate of vertical transmission of human papillomavirus from mothers to infants: relationship between infection rate and mode of delivery. Virol. J. 9, 80 (2012).
  • Derkay CS. Task force on recurrent respiratory papillomas. A preliminary report. Arch. Otolaryngol. Head Neck Surg. 121(12), 1386–1391 (1995).
  • Smith EM, Parker MA, Rubenstein LM, Haugen TH, Hamsikova E, Turek LP. Evidence for vertical transmission of HPV from mothers to infants. Infect. Dis. Obstet. Gynecol. 2010, 326369 (2010).
  • Cason J, Mant CA. High-risk mucosal human papillomavirus infections during infancy & childhood. J. Clin. Virol. 32( Suppl. 1), S52–S58 (2005).
  • Jones V, Smith SJ, Omar HA. Nonsexual transmission of anogenital warts in children: a retrospective analysis. ScientificWorldJournal 7, 1896–1899 (2007).
  • Jayasinghe Y, Garland SM, Genital warts in children: what do they mean? Arch. Dis. Child. 91(8), 696–700 (2006).
  • Marcoux D, Nadeau K, McCuaig C, Powell J, Oligny LL. Pediatric anogenital warts: a 7-year review of children referred to a tertiary-care hospital in Montreal, Canada. Pediatr. Dermatol. 23(3), 199–207 (2006).
  • Sinclair KA, Woods CR, Kirse DJ, Sinal SH. Anogenital and respiratory tract human papillomavirus infections among children: age, gender, and potential transmission through sexual abuse. Pediatrics 116(4), 815–825 (2005).
  • Sinal SH, Woods CR. Human papillomavirus infections of the genital and respiratory tracts in young children. Semin. Pediatr. Infect. Dis. 16(4), 306–316 (2005).
  • Boyd AS. Condylomata acuminata in the pediatric population. Am. J. Dis. Child. 144(7), 817–824 (1990).
  • Aguilera-Barrantes I., Magro C, Nuovo CJ. Verruca vulgaris of the vulva in children and adults: a nonvenereal type of vulvar wart. Am. J. Surg. Pathol. 31(4), 529–535 (2007).
  • Syrjanen S, Puranen M. Human papillomavirus infections in children: the potential role of maternal transmission. Crit. Rev. Oral Biol. Med. 11(2), 259–274 (2000).
  • Matys K, Mallary S, Bautista O et al. Mother-infant transfer of anti-human papillomavirus (HPV) antibodies following vaccination with the quadrivalent HPV (type 6/11/16/18) virus-like particle vaccine. Clin. Vaccine Immunol. 19(6), 881–885 (2012).
  • Heim K, Hudelist G, Geier A et al. Type-specific antiviral antibodies to genital human papillomavirus types in mothers and newborns. Reprod. Sci. 14(8), 806–814 (2007).
  • FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N. Engl. J. Med. 356(19), 1915–1927 (2007).
  • Garland SM, Hernandez-Avila M, Wheeler CM et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N. Engl. J. Med. 356(19), 1928–1943 (2007).
  • FUTURE II Study Group. Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection. J. Infect. Dis. 196(10), 1438–1446 (2007).
  • Joura EA, Garland SM, Paavonen J et al. Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data. BMJ 344, e1401 (2012).
  • Villa LL, Costa RL, Petta CA et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 6(5), 271–278 (2005).
  • Olsson SE, Kjaer SK, Sigurdsson K et al. Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection. Hum. Vaccin. 5(10), 696–704 (2009).
  • Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent human papillomavirus vaccine: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm. Rep. 56(RR-2), 1–24 (2007).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.